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Contraception in Domestic and Wild Animal
Populations Using Zona Pellucida lmmunogens
Bonnie S. Dunbar

Introduction

Conventional Methods of Animal
Population Control

The human population presently exceeds 6 billion and
is continuing to expand at a startling rate. This
population increase has resulted in the depletion of
Earth's resources, which are essential for human
survival. An unfortunate consequence of this expansion has been the destruction of wildlife habitats. As
these habitats have diminished, numerous problems
have arisen. includina conflicts between wildlife and
human populations. The threat of extinction of many
plant and animal species has already become a
reality; other wildlife populations have increased due
to reductions in predator populations. While the
increase in the human population must ultimately be
checked, there is a need for effective and humane
methods to regulate certain animal populations as
well. Another factor relevant to animal overpopulation
is regional distribution. Widespread overpopulation of
such animals as white-tailed deer in North America
and rabbits in Australia has caused environmental as
well as health problems for humans. In Asia and
Africa, the populations of some wildlife species, such
as elephants, have been dramatically reduced. Often
these animals have frequently been relegated to small
areas of land that do not have sufficient resources to
sustain them. There is a vicinal distribution of elephants
in Asia and Africa whose localized high populations
threaten the destruction of their own restricted habitats.

-

The rising domestic pet population also continues to be a problem, as more than 27 million dogs and
cats are impounded annually in the United States, with
more than 17 million of them being euthanized (Carter
1990). The extent of domestic pet overpopulation
poses ethical as well as health-related dilemmas
(Flowers 1979, Carter 1990). Countless dollars are
spent each year to house and dispose of impounded
animals and to combat diseases transmitted by the
fleas and ticks that use the dogs and cats as hosts.
As these problems continue to intensify, it is apparent
that a serious need exists for effective and inexpensive methods of population control.

Despite the need for effective animal population
control, few methods are available which are practical
or cost effective for large-scale administration. The
major methods of current methods are summarized
below.

Surgical Sterilization
Of the surgical sterilization methods recommended for
dogs and cats, the surgical removal of the uterus and
cervix (where possible) as well as the ovary (ovariohysterectomy) has several advantages over partial
removal of reproductive organs.
While neutering of male animals by castration is
also common, this procedure may not ultimately have
a dramatic impact on population reduction in many
animal populations where one virile male can mate
with numerous females. It is also apparent that
surgical procedures are not practical for large-scale
sterilization of major populations of mammalian
wildlife.

Endocrine Regulation of Fertility
Numerous steroid treatments have been tested for
their ability to regulate fertility in animals, including
treatment with progestogens or androgens. In female
dogs, these hormones have been shown to suppress
normal ovarian cyclicity. Many of the treatment
regimens that include progestins have been found to
promote the development of cystic endometrial
hyperplasia and subsequent uterine infection, mammary development, and posttherapy lactation, while
androgens may induce external masculinization.
Alternatively, endocrine administration for the inhibition
of implantation is possible. Because these methods
have adverse effects in some animal species and
because they are expensive and require regular
administration, these methods are not generally
considered to be practical for regulation of large
populations of wildlife; for these reasons, they will not
be dealt with in more detail.

Contraception in Wildlife Management

Contraceptive Vaccines for Animal
Fertility Regulation
The theory that immunization could be used as a
method of contraception has led to numerous investigations into the development of safe and effective
contraceptive vaccines. These vaccines have proposed the use of a variety of antigens as targets that
would be specific for hormones, gametes, or other
reproductive tissues. These vaccines use a variety of
antigens as targets which would be specific for
hormones, gametes, or other reproductive tissues
(see reviews by Alexander et al. [I9901 and Dunbar
and O'Rand [ I 9921). This brief overview is not intended
to provide a detailed outline of all research in this
area.
The development of contraceptive vaccines is
distinct from that of vaccines to control infectious
diseases. Therefore, many of the approaches used in
this area are unique. First, the contraceptive vaccines
will be administered to normal, healthy individuals and
not to infected or ailing individuals. Second, most
traditional vaccines are directed against foreign
organisms such as viruses or bacteria; contraceptive
vaccines must elicit an immune response against
"self" molecules that would not normally be recognized
as foreign. This means that the "self" molecule to be
used in the vaccine must be presented to the body in
a "foreign" or "nonself" form in order for the immune
system to respond effectively. These unique features
have provided a significant challenge to investigators
in the field as described in more detail below.
A second major factor relating to the development of contraceptive vaccines is that the immune
system interacts with the male gonads in a different
way than it does with the female system. It is well
established that there is a blood-testis barrier in the
male that partially protects the developing sperm in
the testis from the immune system. The developing
spermatozoa are formed at a stage long after the
immune system has developed the capability to
distinguish self from nonself antigens. Because
ovaries initiate oocytes before birth in the human and
many other animal species, the same immunological
barriers are not developed. These fundamental

differences have required that vaccines targeted
toward the male be developed in a different manner
than those for the female.
Although the ideal vaccine has yet to be formulated, research has provided a great deal of information relating to the fundamental mechanisms of
hormone action, gamete interaction, fertilization, and
implantation. These detailed studies have been
important not only in laying the foundation for future
development of contraceptive methods but also in
developing a better understanding of reproductive
systems of many mammalian species.
While the development of a contraceptive
vaccine for humans has the criteria that it must be
safe, effective, and potentially reversible, the criteria
for wildlife management are different. In some animal
populations, it is desired (if not required) that animals
be permanently sterilized. In other populations, such
as some captive animals in zoo or farms, it is desirable that the vaccine be reversible. This is an essential requirement where it is important not to deplete a
potential gene pool even though there is temporary
abundance of a species or where there is a temporary
lack of space for housing animals. It is likely, therefore, that several strategies will be necessary to
develop optimal vaccines for different animal species.

Hormone-Based Contraceptive
Vaccines
To date, many of the more applied studies have been
carried out using peptide hormones as immunogens.
These include the peptide hormones, human chorionic
gonadotrophin (hCG), luteinizing hormone (LH), folliclestimulating hormone (FSH), and the gonadotropinreleasing hormones (see review by Stevens [I9881
and articles by Thau et al. [I9871 and Mougdal
[1990]). Of these potential vaccines, the most extensive studies conducted to date have been on the hCG
(see reviews by Gupta and Koothan [I9901 and Griffin
[1991a,b]). The hCG vaccine, which is most advanced in clinical studies for human contraception, is
limited to efficacy in primates and is not applicable to
the majority of wildlife species. Because it interrupts
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pregnancy rather than preventing it, this vaccine may
not be a universally accepted alternative to contraception. Although some of these vaccines have promise
for human contraception, their modes of action make
them less likely to be effective for large-scale animal
populations.

Gamete-Based Contraceptive
Vaccines
Sperm Antigens
The onset of spermatogenesis and the appearance of
mature sperm in the male reproductive tract occur
during puberty at a time well beyond the establishment
of immunological competence and tolerance to
autoantigens (see review by Simon and Alexander
[1988]). The further development of the male gamete
occurs elsewhere in that it must mature in the epididymis (Dacheux et al. 1990, Cameo et al. 1990) and
pass through the male reproductive tract, during which
time the sperm surface antigens are modified (Isojima
and Koyama 1988). Finally, the sperm are further
modified in the female reproductive tract, where sperm
capacitation occurs (Yanagimachi 1989, Bedford
1991). It is therefore possible to interfere with sperm
function at several points in the reproductive process.
Because antibodies are produced against
spermatozoa, Rosenfeld (1926) suggested that
women repeatedly injected with human semen would
become infertile. Since these early investigations,
numerous studies by many laboratories have concentrated on identifying sperm antigens that would be
(1) specific for sperm and not cross-react with any
other cell types so they would not elicit antibodies with
deleterious side effects on other tissues, and (2) present
on the sperm surface or involved in the fertilization
process so that antibodies would be able to inhibit
fertility. These studies have been reviewed in detail
elsewhere (O'Rand and Fisher 1988, Simon and
Alexander 1988). Again, although these vaccines hold
great promise for human vaccine development, they
may not be practical for large-scale animal populations
unless temporary infertility is desired and continuous
and long-term antibodies can be sustained.

Oocyte and Zona Pellucida (ZP)
Antigens
Studies on the identification of oocyte-specific antigens have been less numerous than those of sperm
antigens for the simple reason that large numbers of
mammalian eggs are not readily available to carry out
many of the biochemical studies necessary for such
research. The development of procedures to isolate
large numbers of oocytes with their surrounding egg
coat, the zona pellucida (ZP), has made it possible to
study the study the glycoprotein antigens of the ZP in
great detail (see review by Timmons and Dunbar
[ I 9881).
The antigens of the ZP have long been considered to be an attractive target for immunological
contraceptive or sterilization vaccines for several
reasons. For human contraceptive vaccines, antibodies
directed against the ZP antigens expressed at later
stages of oocyte development should inhibit fertilization (i.e., this would be a nonabortive method). Alternatively, if antibodies are directed against ZP antigens
expressed early in oocyte growth and follicular development, permanent sterilization may result because all
oocytes are ultimately destroyed and no steroids will
be produced. This latter method would be preferable
for use in animal sterilization.
Because there are a limited number of glycoproteins associated with the ZP, the major proteins of
several species have been studied in great detail. To
date, three major glycoproteins have been identified in
most species (see review by Timmons and Dunbar
[1988]). Many studies have demonstrated that both
the immunogenicity and antigenicity of the ZP glycoproteins is extremely complex (see discussion below
on general aspects of immunogenicity and antigenicity).
Antibodies can be identified which recognize amino
acid and carbohydrate epitopes as well as conformational or structural epitopes of the ZP (Maresh and
Dunbar 1987). Further, it is not possible to predict the
immune response of a given animal when immunized
with ZP antigens of a different species. Because
isoimmunization with the ZP glycoproteins of the same
species does not elicit a significant response, it has
become apparent that immunogenicity of ZP is primarily
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due to the foreign epitopes associated with the ZP of
different species. These observations have further
been demonstrated by the necessity to conjugate the
A mouse peptide to the foreign molecule, keyhole
limpet hemocyanin, to elicit an immune response. The
distinct species differences in the antigens of ZP of
different mammalian species and the need to define
antigenic epitopes which will elicit antibodies that
prevent fertilization but do not alter ovarian function
foster the necessity to dissect the antigenic domains
of the ZP glycoproteins.

have demonstrated the rabbit ZP 55 Kd antigen has a
distinct amino acid sequence (Schwoebel et al. 1991)
from the two sequences of mouse ZP proteins
(Ringuette et al. 1986, Liang et al. 1990). Furthermore, the 55 Kd protein does not appear to be present
in the mouse genome. A rabbit 75 Kd ZP protein has
demonstrated significant similarity (70 percent) with
the amino acid sequence of the mouse ZP2 protein,
and cDNA isolated against the 55 Kd rabbit ZP protein
has demonstrated that the pig has a homologue of this
rabbit protein.

Studies have also demonstrated that immunization with some ZP antigens can elicit an immune
response which interferes with development of ovarian
follicles (Skinner et al. 1984, Dunbar et al. 1989, Rhim
et al. 1992, and Lee and Dunbar 1992). These effects
vary among different mammals and may mimic such
clinical conditions as premature ovarian failure, and
polycystic ovarian disease. In the development of
animal sterilization vaccines, it is preferable to eliminate
growing oocytes along with the hormone-secreting
granulosa and theca cells, which are responsible for
estrous behavior. These side effects are not acceptable for the development of a human contraceptive
vaccine.

The complete amino acid sequences of ZP
proteins for several species will ultimately be needed
to determine their species similarities and determine
vaccine efficacy. Results of these studies could
explain why immunization of mice or rats with the ZP
of pig ZP antigens does not cause infertility (Drell et al.
1984, Sacco et al. 1981), while immunization of other
mammalian species including nonhuman primates
with pig ZP proteins effectively reduces fertility (Drell
et al. 1984, Skinner et al. 1984 and 1989, Dunbar et
al. 1989).

In view of these observations and the need to
develop different vaccines which may cause temporary or permanent infertility, it has been necessary to
study the formation and development of the ZP during
ovarian follicular development. These studies have
demonstrated that the ZP proteins are produced in
follicle stage-specific sequence (Wolgemuth et al.
1984, Lee and Dunbar 1992) and that the distinct ZP
antigens are synthesized and secreted at different
stages of development. It should therefore be possible to identify distinct antigenic epitopes that are
associated with the ZP matrix following the differentiation of the steroid-producing granulosa cells.
Molecular biology techniques have allowed for
the further study of ZP proteins' antigenic domains.
Initial studies of molecular cloning and characterization of complimentary deoxyribonucleic acids (cDNA's)
encoding the ZP glycoproteins of mouse and rabbit
have been described (Ringuette et al. 1986, Liang et
al. 1990, and Schwoebel et al. 1991). These studies

Recently, studies have been carried out using
the expression of ZP proteins produced using recombinant DNA techniques to begin to define specific
epitopes that may be effectively used to develop a
contraceptive vaccine. This vaccine would inhibit
fertilization but not affect the early stages of ovarian
follicular development (Schwoebel et al. 1991). These
studies are the first to demonstrate that ZP proteins
produced using bacterially expressed recombinant
DNA techniques can elicit in monkeys antibodies that
recognize the native ZP antigen. Furthermore,
cynomolgus monkeys immunized with 55 Kd rabbit ZP
protein show no alteration of ovarian follicular development, but antibodies to this protein inhibit monkey
sperm from binding to monkey ZP. This is in contrast
to monkeys immunized with a portion of the rabbit
75 Kd rabbit ZP protein, which does alter ovarian
follicular development. Thus, antigenic domains of ZP
proteins can also be dissected to define which ZP
proteins will elicit specific antibodies that either
( I ) inhibit sperm binding to the ZP without affecting
ovarian follicular development or (2) reduce the
number of ovarian follicles and ovulations.
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It is apparent that many studies need to be
carried out to define specific ZP antigens which can
effectively produce an immune response that results in
reversible infertility or permanent sterilization. The
advances in researchers' understanding of the development of the ovary, as well as the advances in
molecular cloning techniques should allow investigators to identity specific antigens rapidly.

Trophoblast Antigens
The principal precursor of the fetal placenta is the
trophoblast, which is composed of a group of cells that
surround the developing embryo at the blastocyst
stage. Research to identify and characterize specific
trophoblast antigens has been important because they
have provided the basis for studying reproductive
failure. The research into the structure and function of
these antigens is important in studies on the maternalfetal interactions that can be used to devise strategies
for improving reproductive success (see review by
Faulk and Hunt [1990]). Although the antigens of the
trophoblast could be used as targets for immunocontraception, the probability that many of antibodies
directed against these antigens would result in abortive mechanism has made the development of this
type of vaccine more controversial.

Maior Goals and Hurdles in
~oitrace~tiv
Vaccine
e
Development
Large-Scale Production of Vaccinogens
To date, development of protein-based contraceptive
vaccines, particularly those using gamete antigens,
has been hampered by the inability to purify sufficient
quantities of protein. However, rapid advances in
recombinant DNA technology and genetic engineering
have now made it possible to generate sufficient
quantities of any target protein antigen (see review by
Chin [1990]). The development of vectors designed
for vaccine delivery systems using virus expression
systems to express large proteins-such as the
vaccinia virus that has been devised for rabies vaccination of wild animals-may also prove useful.

Optimizing Immune Enhancement for
Development of Contraceptive Vaccines
The successful development of contraceptive vaccines,
like other vaccines, will ultimately depend on the
production of an immune response which is sufficient
to elicit antibodies which will neutralize either the
hormone or specific gamete antigens (see review by
Woodrow and Levine [1990]). It is therefore necessary to understand the potential problems in generating a desired immune response using such vaccines.
In general, antigens contain multiple regions (antigenic determinants) that are capable of being recognized by an antibody. These antigenic determinants
may be associated with almost any molecular structure
and may be associated with the peptide backbone of a
protein or a carbohydrate of structure conformation.
lmmunogens have been defined as those chemical
substances that are capable of inducing a specific
immune response (see general discussions by
Benaceraf and Unanue [I9791 and Berzofsky and
Berkower [1989]). Many molecules that are antigenic
are not always immunogenic. In general, immunogenicity can often be achieved by covalently attaching
defined molecules to a larger molecule called a
carrier. Although many such studies have been
carried out to study the immune response experimentally, fewer studies have been carried out to define
specific molecules that can be effectively used in
vaccines.
Another critical factor in the development of
vaccines has been the identification of molecules that
enhance the immune response. The use of adjuvants,
which are agents that potentiate the immune response,
has therefore become common. The term "adjuvant"
has been defined as an agent that augments a specific immune response to antigens (Allison and Byars
1990). The adjuvant most commonly used is Freund's
complete adjuvant, which contains a bacteria suspension in an oil vehicle. When it is inoculated with other
specific antigens, this adjuvant induces a heightened
immune response. Although Freund's is useful as an
enhancing agent, it may also cause a variety of
adverse reactions and is therefore not generally
acceptable for use in clinical trials.
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Recent studies using highly purified antigens
alone have demonstrated the need for adequate
adjuvants that can be used to enhance the immunogenicity molecules that are to be used in vaccines. In
response, a variety of adjuvants have been introduced
(see reviews by Allison and Byars [1990], Anderson
and Capetola [1990], and Alam et al. [1991]), but their
efficacy has yet to be proven in extensive clinical
trials. It is apparent that, until such immune enhancement agents are readily available, many of the immunogens targeted for contraceptive vaccines cannot
effectively be evaluated. The advances being made in
other areas of vaccine development will therefore be
critical for the future development of effective contraceptive vaccines.

Strateav for Develo~mentof
contraceptive vaccines for
Wildlife Populations
Based on observations that all nonrodent mammalian
species tested to date have multiple ZP proteins which
share antigenic determinants with other mammalian
species, it is likely that the ZP proteins of elephant ZP
will also contain similar antigenic determinants. It is
possible to identify such antigens using as few as
20-30 zonae pellucidae using immunoblot analysis of
ZP glycoproteins separated by one- and two-dimensional
poiyacrylamide gel electrophoresis. In this manner, it
is possible to rapidly identify candidate ZP antigens.
These procedures have been successful for identification of horse and deer antigens. Specific polyclonal
as well as monoclonal antibodies are now available to
ZP proteins of numerous mammalian species, and
analyses can easily be used to define specific ZP
antigens of the zonae pellucidae of different wildlife
species. Furthermore, it has been possible to use
cDNA's from the rabbit (Schwoebel et al. 1991) to
isolate a cDNA from the pig's zonae pellucidae and to
use mice ZP cDNA's to isolate human cDNA's
(Chamberlain and Dean 1990, Liang and Dean 1993).
Despite the availability of cDNA sequences for
ZP proteins of numerous species, it will ultimately be
necessary to express sufficient quantities of proteins

to use in fertility studies in target animal species.
Initially, it will be essential to determine if immunization
of individual species with ZP proteins will elicit a
humoral immune response resulting in the production
of antibodies to self ZP antigens. Secondly, it will be
important to establish the stage of ovarian development during which the zonae pellucidae are formed,
as well as the time of transition of oocyte recruitment
from meiotic prophase to the time of ovulation. This
timeframe is estimated to be 2 weeks in mice and up
to 6 months in humans (Gougeon 1982). Because the
time of exposure of oocytes in the developing follicle
to antibodies is critical, it is important to understand
the basic development of the ovary in each mammalian
species for which contraceptive vaccines are being
evaluated. The stage-specific expression of ZP
proteins during ovarian development can easily be
carried out using established immunocytochemistry
methods or in situ hybridization methods. Once these
studies are carried out for a target species, it should
be possible to rapidly evaluate the potential for
efficacy, safety, and reversibility of immunocontraception
using these procedures. In some instances, small
numbers of animals (e.g., elephants and some zoo
animals) will need to be vaccinated for contraception
or sterilization as compared to other large animal or
human populations. It may be necessary, however, to
identify the "species-specific" ZP antigenic domains for
different target animals. Although this identification
could pose a significant challenge, such speciesspecific vaccines will be essential if large-scale oral
vaccine delivery systems are to be utilized.

Considerations for the
Development of Vaccines for
Wildlife Management
In order to design an effective contraceptive or sterilization vaccine for any wildlife species, it is necessary
to take into consideration the long-term effects on the
animal populations. For example, it may be desirable
to develop methods for large-scale sterilization in
animal species that are clearly not in danger of
becoming extinct but whose population has become
so excessive that starvation or other ~roblemsarise.
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If extinction or reduction of the gene pool is, in fact, a
consideration in an animal species, it will be important
to consider contraception rather than sterilization.
Because the zonae pellucidae are composed of
distinct antigens that occur at different stages in
oocyte growth and ovarian follicular development, they
provide target antigens that can be developed to
cause permanent sterilization instead of temporary
contraception. However, the dissection of these
antigenic domains can be carried out only by using
advanced techniques such as recombinant DNA or
peptide chemistry.
The efficacy of these methods is dependent
upon the development of the ovary and the nature of
the ovarian cycle, and it is important to develop a
better understanding of the reproductive cycles of the
females of any animal.

Summary
Development of most of the contraceptive vaccines,
particularly those using gamete antigens, has been
hampered by the inability to purify sufficient quantities
of protein for development and use. The rapid advances in recombinant DNA technology and genetic
engineering have now made it possible to generate
sufficient quantities of any target protein antigen that
has been identified. The use of these techniques for
development of vaccines will ultimately depend on the
production of an immune response sufficient to elicit
antibodies that will neutralize either the hormones or
the specific gamete antigens. This aspect of vaccine
development is greatly dependent upon the production
of more effective and safe adjuvant.
Although the "ideal" vaccine has yet to be
formulated, research in this area has provided a great
deal of information relating to the fundamental mechanisms of hormone action, gamete interaction, fertilization, and implantation. These detailed studies have
been important not only in laying the foundation for the
future development of contraceptive and sterilization
methods but also in developing a better understanding
of reproductive systems that may in turn shed light on
reproductive dysfunction, disease, and infertility.
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